Document is current

Article History

Received: 2 October 2024

Revised: 7 January 2025

Accepted: 12 January 2025

First Online: 22 February 2025

Declarations

:

: R.R. and T.K. are currently serving as president and vice-president of the German Deep Brain Stimulation Working Group (Arbeitsgemeinschaft Tiefe Hirnstimulation e.V.). R.R. received speaker honoraria from Abbot, Boston Scientifc, Esteve and Medtronic, received travel expenses from Boston Scientific, Esteve and Medtronic and served as a consultant for Boston Scientific outside of this work. T.K. received speaker honoraria and research funding from Abbott, Medtronic and Abbvie. C.S. has received fees from serving on the scientific advisory board for Abbvie in the last 3 years, has received honoraria for speaking at conferences from Abbvie, Bial and Desitin in the last 3 years. L.T. serves as editor for Der Nervenarzt, serves as section editor for Neurological Research and Practice, and serves as editor for Cells, has received fees from serving on the scientific advisory board for Abbvie, Bial, Desitin, Stadapharm, Zambon in the last 3 years, has received fees for speaking at conferences from Abbvie, Bial, Desitin, Stadapharm, Zambon in the last 3 years. G.D. has served as a consultant for Boston Scientific, Cavion and Insightec. He receives royalties from Thieme publishers. He receives funding from the German Research Council (SFB 1261, T1) and private foundations. A.A.K. reports research grants from DFG (German Research Foundation)—Project-ID 424778381– TRR 295 and under Germany´s Excellence Strategy—EXC-2049-390688087, Lundbeck Foundation Grant Nr. R336-2020-1035). She also reports personal fees and travel grants by Medtronic, Boston Scientific and Stadapharm. P.K. reports research or educational grants from Swiss National Science Foundation (FNS 323530_177577/FNS 32003BL_197709-1/FNS 33IC30_198772), ROGER DE SPOELBERCH Foundation, Fondation Louis-Jeantet, Carigest, Institut National de la Santé et de la Recherche Médicale, France Parkinson, Edmond Safra Philantropic Foundation, Bertarelli Foundation, Annemarie Opprecht Foundation, Parkinson Schweiz, Michael J Fox Foundation, Aleva Neurotherapeutics, Boston Scientific, Medtronic, St. Jude Medical, GE Healthcare, Idorsia, UCB, all paid to employing institutions; lecturing fees to employing institution from Boston Scientific, Bial, Advisis; travel expenses to scientific meetings from Boston Scientific, Zambon, Abbvie, Merz Pharma (Schweiz) AG. A.Sch. has received lecture fees from Abbott, Novartis, Kyowa Kirin; has been serving as a consultant for Abbott, Zambon, Medtronic Inc; received royalties from Georg Thieme Verlag; received through his institution funding for his research from the German Research Council, Abbott, and the Brunhilde Moll Foundation. A.S. has received funding from the Deutsche Forschungsgemeinschaft (German Research Association) and the Helmholtz-Association outside the present study. He has received honoraria for presentations/advisory boards/consultations from Global Kinetics Corporation (manufacturer of the PKG®), Esteve, Desitin, Lobsor Pharmaceuticals, STADA, Bial, RG Gesellschaft, Zambon, NovoNordisk and AbbVie outside the present study. He has received royalties from Kohlhammer Verlag and Elsevier Press. He serves as an editorial board member of Stem Cells International. C.T. has received funding from BMBF (ERA Net) BRAVA-Project, and the M.J: Fox Foundation outside the present study. She has received honoraria for presentations/advisory boards and consultations from Abbvie, STADA Pharm, UCB, Roche, Boehringer, Bial, Ono Pharm, Esteve, Convatec. She has received royalties from Thieme publisher and license fees from MAPI for PDSS-2. She serves on the editorial Board of Sleep Med and CNS Drugs, associate editor of NRP. G.U.H. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany’s Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy—ID 390857198). He has ongoing research collaborations with Roche, UCB, AbbVie; served as a consultant for Abbvie, Alzprotect, Amylyx, Aprinoia, Asceneuron, Bayer, Bial, Biogen, Biohaven, Epidarex, Ferrer, Kyowa Kirin, Lundbeck, Novartis, Retrotope, Roche, Sanofi, Servier, Takeda, Teva, UCB; received honoraria for scientific presentations from AbbVie, Bayer, Bial, Biogen, Bristol Myers Squibb, Esteve, Kyowa Kirin, Pfizer, Roche, Teva, UCB, Zambon; received publication royalties from Academic Press, Kohlhammer, and Thieme. All authors have contributed to, seen and approved the manuscript.